SLC19A1 Genetic Variation Leads to Altered Thiamine Diphosphate Transport: Implications for the Risk of Developing Wernicke-Korsakoff's Syndrome.


Journal

Alcohol and alcoholism (Oxford, Oxfordshire)
ISSN: 1464-3502
Titre abrégé: Alcohol Alcohol
Pays: England
ID NLM: 8310684

Informations de publication

Date de publication:
10 Sep 2022
Historique:
received: 02 09 2021
revised: 29 04 2022
accepted: 05 07 2022
pubmed: 12 8 2022
medline: 14 9 2022
entrez: 11 8 2022
Statut: ppublish

Résumé

Wernicke-Korsakoff syndrome (WKS) is commonly associated with chronic alcohol misuse, a condition known to have multiple detrimental effects on thiamine metabolism. This study was conducted to identify genetic variants that may contribute to the development of WKS in individuals with alcohol dependence syndrome through alteration of thiamine transport into cells. Exome sequencing data from a panel of genes related to alcohol metabolism and thiamine pathways were analysed in a discovery cohort of 29 individuals with WKS to identify possible genetic risk variants associated with its development. Variant frequencies in this discovery cohort were compared with European frequencies in the Genome Aggregation Database browser, and those present at significantly higher frequencies were genotyped in an additional cohort of 87 alcohol-dependent cases with WKS and 197 alcohol-dependent cognitively intact controls. Thirty non-synonymous variants were identified in the discovery cohort and, after filtering, 23 were taken forward and genotyped in the case-control cohort. Of these SLC19A1:rs1051266:G was nominally associated with WKS. SLC19A1 encodes the reduced folate carrier, a major transporter for physiological folate in plasma; rs1051266 is reported to impact folate transport. Thiamine pyrophosphate (TPP) efflux was significantly decreased in HEK293 cells, stably transfected with rs1051266:G, under thiamine deficient conditions when compared with the efflux from cells transfected with rs1051266:A (P = 5.7 × 10-11). This study provides evidence for the role of genetic variation in the SLC19A1 gene, which may contribute to the development of WKS in vivo through modulation of TPP transport in cells.

Identifiants

pubmed: 35952336
pii: 6661372
doi: 10.1093/alcalc/agac032
doi:

Substances chimiques

Reduced Folate Carrier Protein 0
SLC19A1 protein, human 0
Ethanol 3K9958V90M
Folic Acid 935E97BOY8
Thiamine Pyrophosphate Q57971654Y
Thiamine X66NSO3N35

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

581-588

Subventions

Organisme : Brain Research Foundation

Informations de copyright

© The Author(s) 2022. Medical Council on Alcohol and Oxford University Press. All rights reserved.

Auteurs

Niamh L O'Brien (NL)

Molecular Psychiatry Laboratory, Division of Psychiatry, University College London, UK.

Giorgia Quadri (G)

Molecular Psychiatry Laboratory, Division of Psychiatry, University College London, UK.

Iain Lightley (I)

Centre for Biomarker Research, University of Huddersfield, Huddersfield, UK.

Sally I Sharp (SI)

Molecular Psychiatry Laboratory, Division of Psychiatry, University College London, UK.

Irene Guerrini (I)

Erith Health Centre, South London and Maudsley NHS Foundation Trust, London, UK.
Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.

Iain Smith (I)

Alcohol Related Brain Injury Team, Stirling, UK.

Mathis Heydtmann (M)

Department of Gastroenterology, Dumfries & Galloway Royal Infirmary, Cargenbridge, Dumfries, UK.

Marsha Y Morgan (MY)

UCL Institute for Liver & Digestive Health, Division of Medicine, Royal Free Campus, University College London, UK.

Allan D Thomson (AD)

Molecular Psychiatry Laboratory, Division of Psychiatry, University College London, UK.
Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.

Nicholas J Bass (NJ)

Molecular Psychiatry Laboratory, Division of Psychiatry, University College London, UK.

Patrick C McHugh (PC)

Centre for Biomarker Research, University of Huddersfield, Huddersfield, UK.

Andrew McQuillin (A)

Molecular Psychiatry Laboratory, Division of Psychiatry, University College London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH